Anand Viswanathan Selected Research

Cerebral Amyloid Angiopathy (Congophilic Angiopathy)

1/2022	Vessels Sing Their ARIAs: The Role of Vascular Amyloid in the Age of Aducanumab.
1/2022	Cerebral Small Vessel Disease and Depression Among Intracerebral Hemorrhage Survivors.
1/2022	Effect of vascular amyloid on white matter disease is mediated by vascular dysfunction in cerebral amyloid angiopathy.
1/2022	The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study.
1/2022	Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex.
1/2021	Off-label use of aducanumab for cerebral amyloid angiopathy.
12/2019	Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0.
4/2019	Immunotherapy with ponezumab for probable cerebral amyloid angiopathy.
1/2019	Cortical Superficial Siderosis Evolution.
1/2019	APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anand Viswanathan Research Topics

Disease

33	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 11/2008
32	Cerebral Hemorrhage 08/2022 - 07/2008
16	Stroke (Strokes) 08/2022 - 01/2010
14	Dementia (Dementias) 12/2021 - 11/2008
11	Ischemic Stroke 08/2020 - 07/2008
10	Hematoma 01/2020 - 07/2008
9	Cognitive Dysfunction 06/2022 - 12/2011
9	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 11/2008
9	Hemorrhage 08/2020 - 11/2008
8	Cerebral Small Vessel Diseases 01/2022 - 11/2008
6	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2022 - 01/2014
6	Hypertension (High Blood Pressure) 01/2022 - 05/2014
5	Siderosis 01/2020 - 03/2015
4	Disease Progression 01/2019 - 08/2011
3	Inflammation (Inflammations) 08/2022 - 11/2012
3	Brain Injuries (Brain Injury) 01/2022 - 01/2016
3	Leukoencephalopathies 01/2022 - 04/2013
3	Infections 10/2021 - 12/2010
3	Leukoaraiosis 01/2018 - 04/2013
3	Atrophy 01/2018 - 11/2008
3	Familial Cerebral Amyloid Angiopathy 10/2016 - 11/2008
3	Cystic Fibrosis (Mucoviscidosis) 12/2010 - 08/2006
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2021 - 01/2021
2	Wounds and Injuries (Trauma) 12/2020 - 05/2007
2	Hemorrhagic Stroke 08/2020 - 01/2020
2	Aphasia (Dysphasia) 04/2019 - 11/2013
2	Atrial Fibrillation 01/2019 - 11/2018
2	Leukemia 12/2010 - 08/2006
1	Cerebral Infarction 08/2022
1	Neurologic Manifestations (Neurological Manifestations) 06/2022
1	Clostridium Infections 10/2021
1	COVID-19 12/2020
1	Thromboembolism 01/2020
1	Subdural Hematoma (Subdural Hemorrhage) 04/2019
1	Edema (Dropsy) 04/2019
1	Autistic Disorder (Autism) 01/2019
1	Nausea 01/2019
1	Vomiting 01/2019
1	Autism Spectrum Disorder 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019
1	Embolic Stroke 11/2018
1	Neurobehavioral Manifestations 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Infarction (Infarctions) 11/2017
1	Genetic Risk Score 10/2017
1	Lacunar Stroke 10/2017
1	Vascular System Injuries 07/2017
1	Hypoalbuminemia 05/2017
1	Critical Illness (Critically Ill) 05/2017
1	Medulloblastoma 02/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017

Drug/Important Bio-Agent (IBA)

22	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2009
18	Apolipoproteins E (ApoE)IBA 12/2021 - 12/2010
14	Biomarkers (Surrogate Marker)IBA 08/2022 - 11/2008
9	ApolipoproteinsIBA 06/2022 - 06/2012
6	Biological ProductsIBA 08/2022 - 01/2014
6	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 09/2014
4	LipidsIBA 01/2019 - 07/2015
4	CholesterolIBA 01/2019 - 05/2014
4	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 01/2012
4	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2018 - 11/2008
3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 06/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2014 - 07/2008
2	Indicators and Reagents (Reagents)IBA 08/2022 - 11/2008
2	aducanumabIBA 01/2022 - 01/2021
2	Contrast MediaIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2017
2	Amyloid beta-PeptidesIBA 01/2018 - 11/2008
2	AnticoagulantsIBA 12/2016 - 10/2016
2	ChloridesIBA 12/2010 - 08/2006
2	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2010 - 08/2006
1	COVID-19 VaccinesIBA 06/2022
1	Waste Products (Waste Product)IBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	Proton Pump InhibitorsIBA 10/2021
1	TroponinIBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2020
1	Nicardipine (Dagan)FDA LinkGeneric 01/2020
1	ponezumabIBA 04/2019
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2019
1	OzoneIBA 10/2018
1	Environmental Pollutants (Pollutants, Environmental)IBA 10/2018
1	CreatinineIBA 01/2018
1	florbetapirIBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Pemetrexed (MTA)FDA Link 01/2018
1	Peroxidase (Myeloperoxidase)IBA 10/2017
1	ORALIT (ORS)IBA 08/2017
1	AlbuminsIBA 05/2017
1	Serum AlbuminIBA 05/2017

Therapy/Procedure

9	Therapeutics 01/2022 - 05/2007
2	Immunotherapy 01/2022 - 04/2019
2	Thrombectomy 11/2017 - 01/2017
1	Off-Label Use 01/2021
1	Replacement Arthroplasty 12/2020
1	Hand Hygiene 12/2020
1	Craniospinal Irradiation 02/2017
1	Cranial Irradiation 02/2017
1	Activities of Daily Living (ADL) 01/2017